Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 336-343

  Tai, Cheng Jeng ^a,b   Chin Sheng, Hung ^a,b   Kuo, Li Jen ^a,b   Wei, Po Li ^a,b   Lu, Hsuan Hsuan ^a   Chen, Hsin An ^c   Liu, Tsan Zon ^a   Liu, Jun Jen ^b,d   Liu, Der Zen ^d   Ho, Yuan Soon ^b,d   Wu, Chih Hsiung ^a,b,c   Chang, Yu Jia ^a,b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; SMALL INTERFERING RNA; SURVIVIN; VIMENTIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN HEP3B; CELL STRAIN MAHLAVU; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; METASTASIS; METASTASIS POTENTIAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 84856676775     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1692-5     Document Type: Article

References (41)

1. FX Bosch J Ribes R Cleries M Díaz 2005 Epidemiology of hepatocellular carcinoma Clin Liver Dis. 9 191 211 15831268 10.1016/j.cld.2004. 12.009
2. SM Srinivasula JD Ashwell 2008 IAPs: what's in a name? Mol Cell. 30 123 135 18439892 10.1016/j.molcel.2008.03.008 1:CAS:528:DC%2BD1cXlsFentLY%3D
3. DC Altieri 2008 Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer. 8 61 70 18075512 10.1038/nrc2293 1:CAS:528: DC%2BD2sXhsVKku73M
4. DC Altieri 2006 Targeted therapy by disabling crossroad signaling networks: the survivin paradigm Mol Cancer Ther. 5 478 482 16546961 10.1158/1535-7163.MCT-05-0436 1:CAS:528:DC%2BD28Xitl2ls7c%3D
5. DC Altieri 2003 Survivin in apoptosis control and cell cycle regulation in cancer Prog Cell Cycle Res. 5 447 452 14593739
6. DC Altieri 2003 Blocking survivin to kill cancer cells Methods Mol Biol. 223 533 542 12777749 1:CAS:528:DC%2BD3sXkt1Ggtr0%3D
7. CC Lin E Calvo KP Papadopoulos A Patnaik J Sarantopoulos AC Mita, et al. 2009 Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors Cancer Chemother Pharmacol. 63 1065 1071 18795291 10.1007/s00280-008-0811-x 1:CAS:528:DC%2BD1MXjslOlur0%3D
8. F Li EJ Ackermann CF Bennett AL Rothermel J Plescia S Tognin, et al. 1999 Pleiotropic cell-division defects and apoptosis induced by interference with survivin function Nat Cell Biol. 1 461 466 10587640 10.1038/70242 1:CAS:528:DyaK1MXotFaltbo%3D
9. T Ito K Shiraki K Sugimoto T Yamanaka K Fujikawa M Ito, et al. 2000 Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology. 31 1080 1085 10796883 10.1053/he.2000.6496 1:CAS:528: DC%2BD3cXjtlyltbg%3D
10. JM Llovet Y Chen E Wurmbach S Roayaie MI Fiel M Schwartz, et al. 2006 A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis Gastroenterology. 131 1758 1767 17087938 10.1053/j.gastro.2006.09.014 1:CAS:528:DC%2BD2sXhtFyltLg%3D
11. B Liu QX Bai XQ Chen GX Gao HT Gu 2007 Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line Zhongguo Shi Yan Xue Ye Xue Za Zhi. 15 762 766 17708799 1:CAS:528:DC%2BD1cXovFKnurY%3D
12. RA Olie AP Simoes-Wust B Baumann SH Leech D Fabbro RA Stahel, et al. 2000 A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy Cancer Res. 60 2805 2809 10850418 1:CAS:528:DC%2BD3cXjvFOlsLo%3D
13. D Grossman JM McNiff F Li DC Altieri 1999 Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma J Invest Dermatol. 113 1076 1081 10594755 10.1046/j.1523-1747.1999.00776.x 1:CAS:528:DC%2BD3cXhtFGgtg%3D%3D
14. SH Leech RA Olie O Gautschi AP Simões-Wüst S Tschopp R Häner, et al. 2000 Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment Int J Cancer. 86 570 576 10797273 10.1002/(SICI)1097-0215(20000515)86:4<570::AID-IJC20>3.0.CO;2-T 1:CAS:528:DC%2BD3cXjtlyksLk%3D
15. KW Feldman R Bethel RP Shugerman DC Grossman MS Grady RG Ellenbogen 2001 The cause of infant and toddler subdural hemorrhage: a prospective study Pediatrics. 108 636 646 11533330 10.1542/peds.108.3.636 1:STN:280: DC%2BD3MvptFSlsQ%3D%3D
16. XX Duan JS Ou Y Li JJ Su C Ou C Yang, et al. 2005 Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis World J Gastroenterol. 11 4740 4744 16094721 1:CAS:528:DC%2BD2MXhtVyiurnP
17. JM Lopez-Novoa MA Nieto 2009 Inflammation and EMT: an alliance towards organ fibrosis and cancer progression EMBO Mol Med. 1 303 314 20049734 10.1002/emmm.200900043 1:CAS:528:DC%2BD1MXhsVSltL%2FJ
18. M Yilmaz G Christofori 2009 EMT, the cytoskeleton, and cancer cell invasion Cancer Metastasis Rev. 28 15 33 19169796 10.1007/s10555-008-9169-0
19. MA Huber N Kraut H Beug 2005 Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol. 17 548 558 16098727 10.1016/j.ceb.2005.08.001 1:CAS:528:DC%2BD2MXhtVWnsb7L
20. B Ozdamar R Bose M Barrios-Rodiles HR Wang Y Zhang JL Wrana 2005 Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity Science. 307 1603 1609 15761148 10.1126/science.1105718 1:CAS:528:DC%2BD2MXitV2isLs%3D
21. H Peinado D Olmeda A Cano 2007 Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 7 415 428 17508028 10.1038/nrc2131 1:CAS:528:DC%2BD2sXls1Kjs70%3D
22. LS Orlichenko DC Radisky 2008 Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development Clin Exp Metastasis. 25 593 600 18286378 10.1007/s10585-008-9143-9 1:CAS:528:DC%2BD1cXhtVeis7fF
23. E Vincan N Barker 2008 The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression Clin Exp Metastasis. 25 657 663 18350253 10.1007/s10585-008-9156-4 1:CAS:528:DC%2BD1cXhtVeisL7E
24. XL Zhao T Sun N Che D Sun N Zhao XY Dong, et al. 2011 Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator twist1 J Cell Mol Med. 15 691 700 20219012 10.1111/j.1582-4934.2010.01052.x 1:CAS:528:DC%2BC3MXmslWlsr0%3D
25. M Guha DC Altieri 2009 Survivin as a global target of intrinsic tumor suppression networks Cell Cycle. 8 2708 2710 19717980 10.4161/cc.8.17.9457 1:CAS:528:DC%2BC3cXkslWit7g%3D
26. CP Ye CZ Qiu ZX Huang QC Su W Zhuang RL Wu, et al. 2007 Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma World J Gastroenterol. 13 6264 6268 18069771 10.3748/wjg.13.6264
27. S Peroukides V Bravou A Alexopoulos J Varakis H Kalofonos H Papadaki 2010 Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin Histol Histopathol. 25 299 307 20054802 1:CAS:528:DC%2BC3cXislamt7g%3D
28. JF Chiou CJ Tai MT Huang PL Wei YH Wang J An, et al. 2010 Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma Ann Surg Oncol. 17 603 612 19830497 10.1245/s10434-009-0718-8
29. YJ Chang CC Chiu CH Wu J An CC Wu TZ Liu, et al. 2010 Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma Ann Surg Oncol. 17 1703 1709 20087778 10.1245/s10434-010-0912-8
30. LH Zhang X Zhang 2010 Roles of GRP78 in physiology and cancer J Cell Biochem. 110 1299 1305 20506407 10.1002/jcb.22679 1:CAS:528:DC%2BC3cXovFKrurw%3D
31. MV Backer JM Backer P Chinnaiyan 2011 Targeting the unfolded protein response in cancer therapy Methods Enzymol. 491 37 56 21329793 10.1016/B978-0-12-385928-0.00003-1 1:CAS:528:DC%2BC3MXlt1WjtL8%3D
32. PL Wei YJ Chang YS Ho CH Lee YY Yang J An, et al. 2009 Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor Ann Surg. 249 978 985 19474681 10.1097/SLA. 0b013e3181a6ce7e
33. MT Huang PL Wei JJ Liu DZ Liu H Huey-Chun J An, et al. 2010 Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression Ann Surg Oncol. 17 3379 3385 20625840 10.1245/s10434-010-1163-4
34. Wei P-L, Kuo L-J, Huang M-T, Ting W-C, Ho Y-S, Wang W, et al. Nicotine enhances colon cancer cell migration by induction of fibronectin. Ann Surg Oncol 2011. doi 10.1245/s10434-010-1504-3.
35. SK Wang PH Liang RD Astronomo TL Hsu SL Hsieh DR Burton, et al. 2008 Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN Proc Natl Acad Sci U S A. 105 3690 3695 18310320 10.1073/pnas.0712326105 1:CAS:528:DC%2BD1cXjs1Oit7s%3D
36. S Sowinski C Jolly O Berninghausen MA Purbhoo A Chauveau K Köhler, et al. 2008 Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission Nat Cell Biol. 10 211 219 18193035 10.1038/ncb1682 1:CAS:528:DC%2BD1cXhs1Kiuro%3D
37. D Dong B Ko P Baumeister S Swenson F Costa F Markland, et al. 2005 Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment Cancer Res. 65 5785 5791 15994954 10.1158/0008-5472.CAN-05-0754 1:CAS:528:DC%2BD2MXlslOqsbg%3D
38. P Gimenez-Bonafe A Tortosa R Perez-Tomas 2009 Overcoming drug resistance by enhancing apoptosis of tumor cells Curr Cancer Drug Targets. 9 320 340 19442052 10.2174/156800909788166600 1:CAS:528:DC%2BD1MXmslansLs%3D
39. Y Sun R Lin J Dai D Jin SQ Wang 2006 Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice Oligonucleotides. 16 365 374 17155911 10.1089/oli.2006.16.365 1:CAS:528:DC%2BD28Xht12gtLfK
40. LC Dai X Wang X Yao YL Lu JL Ping JF He 2006 Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells Acta Pharmacol Sin. 27 1630 1636 17112419 10.1111/j.1745-7254.2006.00459.x 1:CAS:528:DC%2BD28XhtlemsbnK
41. H Zhu XP Chen WG Zhang SF Luo BX Zhang 2005 Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma World J Gastroenterol. 11 3855 3859 15991282 1:CAS:528:DC%2BD2MXhtVemsLrE